{"id":57619,"date":"2026-06-04T21:37:17","date_gmt":"2026-06-04T12:37:17","guid":{"rendered":"https:\/\/japanir.jp\/en\/company\/company-4563\/"},"modified":"2026-08-09T13:29:20","modified_gmt":"2026-08-09T04:29:20","slug":"company-4563","status":"publish","type":"company","link":"https:\/\/japanir.jp\/en\/company\/company-4563\/","title":{"rendered":"ANGES INC"},"content":{"rendered":"","protected":false},"featured_media":0,"template":"","meta":{"Ticker":"4563","DATE":"2026-01-09","longName":"AnGes, Inc.","company_name_ja":"","fullTimeEmployees":56,"address":"","phone":"","website":"https:\/\/www.anges.co.jp","industry":"Biotechnology","sector":"Healthcare","regularMarketPrice":63,"financialCurrency":"","marketCap":24322,"fiftyTwoWeekLow":0,"fiftyTwoWeekHigh":0,"epsTrailingTwelveMonths":-14.44,"epsForward":0,"bookValue":0,"totalRevenue":874119000,"OperatingIncome":-5145394000,"operatingMargins":-588.63999999999999,"NetIncome":-5123269000,"profitMargins":-586.11000000000001,"ebitda":0,"trailingPE":0,"forwardPE":0,"priceToBook":0,"returnOnEquity":-166.55000000000001,"recommendationMean":0,"recommendationKey":"none","targetMeanPrice":0,"numberOfAnalystOpinions":0,"analyst_earnings_data":"{\"success\": true, \"fetched_at\": \"2026-08-01T04:18:17.741328\", \"ticker\": \"4563\", \"ticker_full\": \"4563.T\", \"company_name\": \"ANGES INC\", \"analyst_recommendations\": {\"has_data\": true, \"recommendation_key\": \"none\", \"recommendation_mean\": null, \"total_analysts\": null, \"strong_buy\": null, \"buy\": null, \"hold\": null, \"sell\": null, \"strong_sell\": null}, \"target_prices\": {\"has_data\": true, \"current\": 47.0, \"high\": null, \"low\": null, \"mean\": null, \"median\": null}, \"earnings_dates\": {\"has_data\": true, \"next_earnings\": {\"date\": \"2026-08-07\", \"eps_estimate\": null, \"eps_actual\": null, \"surprise_pct\": null}, \"future_count\": 1, \"past_earnings\": []}, \"shareholders\": {\"has_data\": true, \"insider_pct\": 6.34, \"institution_pct\": 5.45, \"major_holders\": [{\"label\": \"\", \"value\": 6.34}, {\"label\": \"\", \"value\": 5.45}, {\"label\": \"\", \"value\": 5.82}, {\"label\": \"\", \"value\": 6.0}], \"institutional_holders\": [{\"holder\": \"SPDR INDEX SHARES Fd.S-State Street SPDR S&P Intl Small Cap ETF\", \"shares\": 85600, \"date_reported\": \"2026-06-30\", \"pct_held\": 0.02, \"pct_change\": 1.42, \"value\": 4023200}], \"mutualfund_holders\": []}}","dividendRate":0,"dividendYield":0,"payoutRatio":0,"totalEsg":0,"environmentScore":0,"socialScore":0,"governanceScore":0,"title":"","providerPublishTime":"","link":"","longBusinessSummary":"AnGes, Inc. engages in the research and development of gene-based medicines. It develops HGF gene therapy product for the treatment of chronic arterial occlusive disease; NF-KB decoy oligonucleotide for chronic discogenic lumbar back pain; and DNA vaccines for the treatment of hypertension, as well as tie2 agonists for COVID-19\/ARDS and drugs for chronic hepatitis B. AnGes, Inc. was formerly known as AnGes MG, Inc. and changed its name to AnGes, Inc. in July 2017. The company was incorporated in 1999 and is headquartered in Ibaraki, Japan.","longBusinessSummary_ja":"","quarterly_revenue":0,"quarterly_net_income":0,"quarterly_operating_profit":0,"enterprise_value":0,"company_officer_1_name":"","company_officer_1_title":"","company_officer_2_name":"","company_officer_2_title":"","company_officer_3_name":"","company_officer_3_title":"","company_officer_4_name":"","company_officer_4_title":"","company_officer_5_name":"","company_officer_5_title":"","company_officers_update_time":"","get_dividend_history_year1":0,"get_dividend_history_year2":0,"get_dividend_history_year3":0,"get_dividend_history_year4":0,"get_dividend_history_year5":0,"get_dividend_history_year6":0,"get_dividend_history_year7":0,"get_dividend_history_year8":0,"get_dividend_history_year9":0,"get_dividend_history_year10":0,"site-sidebar-layout":"default","site-content-layout":"","ast-site-content-layout":"","site-content-style":"default","site-sidebar-style":"default","ast-global-header-display":"","ast-banner-title-visibility":"","ast-main-header-display":"","ast-hfb-above-header-display":"","ast-hfb-below-header-display":"","ast-hfb-mobile-header-display":"","site-post-title":"","ast-breadcrumbs-content":"","ast-featured-img":"","footer-sml-layout":"","theme-transparent-header-meta":"","adv-header-id-meta":"","stick-header-meta":"","header-above-stick-meta":"","header-main-stick-meta":"","header-below-stick-meta":"","astra-migrate-meta-layouts":"default","ast-page-background-enabled":"default","ast-page-background-meta":{"desktop":{"background-color":"var(--ast-global-color-5)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"tablet":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"mobile":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""}},"ast-content-background-meta":{"desktop":{"background-color":"var(--ast-global-color-4)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"tablet":{"background-color":"var(--ast-global-color-4)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"mobile":{"background-color":"var(--ast-global-color-4)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""}},"financial_data":"","detailed_financial_data":"{\"success\": true, \"fetched_at\": \"2026-08-09T02:43:38.940612\", \"ticker\": \"4563\", \"ticker_full\": \"4563.T\", \"company_name\": \"ANGES INC\", \"company_info\": {\"name_en\": \"ANGES INC\", \"long_name\": \"AnGes, Inc.\", \"sector\": \"Healthcare\", \"industry\": \"Biotechnology\", \"website\": \"https:\/\/www.anges.co.jp\", \"employees\": 56, \"country\": \"Japan\", \"city\": \"Ibaraki\", \"address\": \"Saito Bio-Incubator\", \"description\": \"AnGes, Inc. engages in the research and development of gene-based medicines. It develops HGF gene therapy product for the treatment of chronic arterial occlusive disease; NF-KB decoy oligonucleotide for chronic discogenic lumbar back pain; and DNA vaccines for the treatment of hypertension, as well as tie2 agonists for COVID-19\/ARDS and drugs for chronic hepatitis B. AnGes, Inc. was formerly known as AnGes MG, Inc. and changed its name to AnGes, Inc. in July 2017. The company was incorporated in 1999 and is headquartered in Ibaraki, Japan.\"}, \"price_trend\": {\"ma_5\": {\"ma_value\": 48.0, \"deviation\": 0.0, \"trend\": \"down\"}, \"ma_25\": {\"ma_value\": 48.6, \"deviation\": -1.23, \"trend\": \"down\"}, \"ma_75\": {\"ma_value\": 48.97, \"deviation\": -1.99, \"trend\": \"down\"}, \"ma_200\": {\"ma_value\": 58.91, \"deviation\": -18.53, \"trend\": \"down\"}}, \"financials\": {\"years\": [{\"year\": 2025, \"revenue\": 874119000.0, \"revenue_fmt\": \"\u00a59\u5104\", \"gross_profit\": 320382000.0, \"gross_profit_fmt\": \"\u00a53\u5104\", \"operating_income\": -5145394000.0, \"operating_income_fmt\": \"-\u00a551\u5104\", \"ebit\": -5145394000.0, \"ebit_fmt\": \"-\u00a551\u5104\", \"net_income\": -5123269000.0, \"net_income_fmt\": \"-\u00a551\u5104\", \"eps\": -14.44, \"operating_margin\": -588.64, \"total_assets\": 5405983000.0, \"total_assets_fmt\": \"\u00a554\u5104\", \"total_equity\": 3076079000.0, \"total_equity_fmt\": \"\u00a531\u5104\", \"total_debt\": 54368000.0, \"total_debt_fmt\": \"\u00a554.4M\", \"total_cash\": 1882005000.0, \"total_cash_fmt\": \"\u00a519\u5104\", \"equity_ratio\": 56.9, \"de_ratio\": 0.02, \"current_ratio\": 1.96, \"operating_cf\": -5750366000.0, \"operating_cf_fmt\": \"-\u00a558\u5104\", \"investing_cf\": 18814000.0, \"investing_cf_fmt\": \"\u00a518.8M\", \"financing_cf\": 5902042000.0, \"financing_cf_fmt\": \"\u00a559\u5104\", \"free_cf\": -5764688000.0, \"free_cf_fmt\": \"-\u00a558\u5104\", \"net_margin\": -586.11, \"roe\": -166.55, \"roa\": -94.77}, {\"year\": 2024, \"revenue\": 643638000.0, \"revenue_fmt\": \"\u00a56\u5104\", \"gross_profit\": 247703000.0, \"gross_profit_fmt\": \"\u00a52\u5104\", \"operating_income\": -9109445000.0, \"operating_income_fmt\": \"-\u00a591\u5104\", \"ebit\": -9109445000.0, \"ebit_fmt\": \"-\u00a591\u5104\", \"net_income\": -28128983000.0, \"net_income_fmt\": \"-\u00a5281\u5104\", \"eps\": -119.53, \"operating_margin\": -1415.31, \"total_assets\": 4668599000.0, \"total_assets_fmt\": \"\u00a547\u5104\", \"total_equity\": 2156590000.0, \"total_equity_fmt\": \"\u00a522\u5104\", \"total_debt\": 272448000.0, \"total_debt_fmt\": \"\u00a53\u5104\", \"total_cash\": 1707756000.0, \"total_cash_fmt\": \"\u00a517\u5104\", \"equity_ratio\": 46.19, \"de_ratio\": 0.13, \"current_ratio\": 1.53, \"operating_cf\": -6612875000.0, \"operating_cf_fmt\": \"-\u00a566\u5104\", \"investing_cf\": -130801000.0, \"investing_cf_fmt\": \"-\u00a51\u5104\", \"financing_cf\": 4202127000.0, \"financing_cf_fmt\": \"\u00a542\u5104\", \"free_cf\": -6690327000.0, \"free_cf_fmt\": \"-\u00a567\u5104\", \"net_margin\": -4370.31, \"roe\": -1304.33, \"roa\": -602.51}, {\"year\": 2023, \"revenue\": 152985000.0, \"revenue_fmt\": \"\u00a52\u5104\", \"gross_profit\": 19445000.0, \"gross_profit_fmt\": \"\u00a519.4M\", \"operating_income\": -11967504000.0, \"operating_income_fmt\": \"-\u00a5120\u5104\", \"ebit\": -11967504000.0, \"ebit_fmt\": \"-\u00a5120\u5104\", \"net_income\": -7437607000.0, \"net_income_fmt\": \"-\u00a574\u5104\", \"eps\": -39.29, \"operating_margin\": -7822.66, \"total_assets\": 28892536000.0, \"total_assets_fmt\": \"\u00a5289\u5104\", \"total_equity\": 26103166000.0, \"total_equity_fmt\": \"\u00a5261\u5104\", \"total_debt\": 362675000.0, \"total_debt_fmt\": \"\u00a54\u5104\", \"total_cash\": 4160424000.0, \"total_cash_fmt\": \"\u00a542\u5104\", \"equity_ratio\": 90.35, \"de_ratio\": 0.01, \"current_ratio\": 2.38, \"operating_cf\": -8745759000.0, \"operating_cf_fmt\": \"-\u00a587\u5104\", \"investing_cf\": -356653000.0, \"investing_cf_fmt\": \"-\u00a54\u5104\", \"financing_cf\": 2036465000.0, \"financing_cf_fmt\": \"\u00a520\u5104\", \"free_cf\": -8835090000.0, \"free_cf_fmt\": \"-\u00a588\u5104\", \"net_margin\": -4861.66, \"roe\": -28.49, \"roa\": -25.74}, {\"year\": 2022, \"revenue\": 67060000.0, \"revenue_fmt\": \"\u00a567.1M\", \"gross_profit\": -26829000.0, \"gross_profit_fmt\": \"-\u00a526.8M\", \"operating_income\": -16316803000.0, \"operating_income_fmt\": \"-\u00a5163\u5104\", \"ebit\": -16316803000.0, \"ebit_fmt\": \"-\u00a5163\u5104\", \"net_income\": -14714772000.0, \"net_income_fmt\": \"-\u00a5147\u5104\", \"eps\": -94.29, \"operating_margin\": -24331.65, \"total_assets\": 38820711000.0, \"total_assets_fmt\": \"\u00a5388\u5104\", \"total_equity\": 30425406000.0, \"total_equity_fmt\": \"\u00a5304\u5104\", \"total_debt\": 1155712000.0, \"total_debt_fmt\": \"\u00a512\u5104\", \"total_cash\": 11035102000.0, \"total_cash_fmt\": \"\u00a5110\u5104\", \"equity_ratio\": 78.37, \"de_ratio\": 0.04, \"current_ratio\": 1.76, \"operating_cf\": -11214246000.0, \"operating_cf_fmt\": \"-\u00a5112\u5104\", \"investing_cf\": -97141000.0, \"investing_cf_fmt\": \"-\u00a597.1M\", \"financing_cf\": 3572543000.0, \"financing_cf_fmt\": \"\u00a536\u5104\", \"free_cf\": -11233815000.0, \"free_cf_fmt\": \"-\u00a5112\u5104\", \"net_margin\": -21942.7, \"roe\": -48.36, \"roa\": -37.9}], \"has_data\": true}, \"dividends\": {\"history\": [], \"has_data\": false}}","ma_5_value":0,"ma_5_deviation":0,"ma_5_trend":"","ma_25_value":0,"ma_25_deviation":0,"ma_25_trend":"","ma_75_value":0,"ma_75_deviation":0,"ma_75_trend":"","ma_200_value":0,"ma_200_deviation":0,"ma_200_trend":"","previousClose":0,"open":0,"dayHigh":0,"dayLow":0,"volume":0,"averageVolume":0,"revenueGrowth":0},"sector":[],"class_list":["post-57619","company","type-company","status-publish","hentry"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v24.7 - https:\/\/yoast.com\/wordpress\/plugins\/seo\/ -->\n<title>ANGES INC - Japan IR<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/japanir.jp\/en\/company\/company-4563\/\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\/\/japanir.jp\/en\/company\/company-4563\/\",\"url\":\"https:\/\/japanir.jp\/en\/company\/company-4563\/\",\"name\":\"ANGES INC - Japan IR\",\"isPartOf\":{\"@id\":\"https:\/\/japanir.jp\/en\/#website\"},\"datePublished\":\"2026-06-04T12:37:17+00:00\",\"dateModified\":\"2026-08-09T04:29:20+00:00\",\"breadcrumb\":{\"@id\":\"https:\/\/japanir.jp\/en\/company\/company-4563\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/japanir.jp\/en\/company\/company-4563\/\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/japanir.jp\/en\/company\/company-4563\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/japanir.jp\/en\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"ANGES INC\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/japanir.jp\/en\/#website\",\"url\":\"https:\/\/japanir.jp\/en\/\",\"name\":\"Japan IR\",\"description\":\"\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/japanir.jp\/en\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"ANGES INC - Japan IR","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/japanir.jp\/en\/company\/company-4563\/","schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/japanir.jp\/en\/company\/company-4563\/","url":"https:\/\/japanir.jp\/en\/company\/company-4563\/","name":"ANGES INC - Japan IR","isPartOf":{"@id":"https:\/\/japanir.jp\/en\/#website"},"datePublished":"2026-06-04T12:37:17+00:00","dateModified":"2026-08-09T04:29:20+00:00","breadcrumb":{"@id":"https:\/\/japanir.jp\/en\/company\/company-4563\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/japanir.jp\/en\/company\/company-4563\/"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/japanir.jp\/en\/company\/company-4563\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/japanir.jp\/en\/"},{"@type":"ListItem","position":2,"name":"ANGES INC"}]},{"@type":"WebSite","@id":"https:\/\/japanir.jp\/en\/#website","url":"https:\/\/japanir.jp\/en\/","name":"Japan IR","description":"","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/japanir.jp\/en\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"}]}},"_links":{"self":[{"href":"https:\/\/japanir.jp\/en\/wp-json\/wp\/v2\/company\/57619","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/japanir.jp\/en\/wp-json\/wp\/v2\/company"}],"about":[{"href":"https:\/\/japanir.jp\/en\/wp-json\/wp\/v2\/types\/company"}],"wp:attachment":[{"href":"https:\/\/japanir.jp\/en\/wp-json\/wp\/v2\/media?parent=57619"}],"wp:term":[{"taxonomy":"sector","embeddable":true,"href":"https:\/\/japanir.jp\/en\/wp-json\/wp\/v2\/sector?post=57619"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}